ATE147755T1 - Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten - Google Patents

Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten

Info

Publication number
ATE147755T1
ATE147755T1 AT93109551T AT93109551T ATE147755T1 AT E147755 T1 ATE147755 T1 AT E147755T1 AT 93109551 T AT93109551 T AT 93109551T AT 93109551 T AT93109551 T AT 93109551T AT E147755 T1 ATE147755 T1 AT E147755T1
Authority
AT
Austria
Prior art keywords
prophylactic
therapeutic agent
active ingredients
bone diseases
agent against
Prior art date
Application number
AT93109551T
Other languages
English (en)
Inventor
Naoki Higuchi
Masayuki Saitoh
Shinjiro Niwata
Yoshinobu Kiso
Yasuhiro Hayashi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE147755T1 publication Critical patent/ATE147755T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93109551T 1992-06-15 1993-06-15 Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten ATE147755T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4155115A JPH05345754A (ja) 1992-06-15 1992-06-15 ジペプチド誘導体およびそれを有効成分とする骨疾患の予防または治療剤

Publications (1)

Publication Number Publication Date
ATE147755T1 true ATE147755T1 (de) 1997-02-15

Family

ID=15598916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93109551T ATE147755T1 (de) 1992-06-15 1993-06-15 Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten

Country Status (5)

Country Link
US (1) US5399743A (de)
EP (1) EP0578978B1 (de)
JP (1) JPH05345754A (de)
AT (1) ATE147755T1 (de)
DE (1) DE69307414T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
AU3841500A (en) * 1999-04-22 2000-11-10 Sankyo Company Limited Resin-bearing ketoamides and process for the preparation thereof
JP6859559B2 (ja) * 2017-03-16 2021-04-14 二村 芳弘 抗アレルギー作用を呈するフェニルペプチド誘導体
EP4079748A1 (de) * 2021-04-23 2022-10-26 Insusense ApS Modulatoren von sortilinaktivität

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206487A (en) * 1968-06-04 1970-09-23 Beecham Group Ltd Derivatives of n-acylaminoacid amides
CH626872A5 (de) * 1976-06-21 1981-12-15 Hoffmann La Roche
PH14141A (en) * 1976-06-25 1981-03-05 Hoffmann La Roche Pharmaceutical composition containing dipeptide derivatives
DE3274985D1 (en) * 1981-09-21 1987-02-12 Toyo Soda Mfg Co Ltd Process for recovering a dipeptide derivative
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
FR2588555B1 (fr) * 1985-10-16 1987-12-11 Atochem Monomeres acryliques fluores, polymeres en derivant et leur application au traitement hydrofuge et oleofuge de substrats divers
EP0269311A3 (de) * 1986-11-17 1990-06-06 Merck & Co. Inc. Methoden zur Behandlung von Knochenleiden mittels Verabreichung von Cystein-Proteinaseinhibitoren
ATE81500T1 (de) * 1987-07-23 1992-10-15 Ciba Geigy Ag Verfahren zur selektiven n-acylierung von amino- hydroxamsaeurederivaten und darin verwendete ausgangsstoffe.
JPH02218610A (ja) * 1989-02-21 1990-08-31 Toyo Jozo Co Ltd 骨疾患の予防および治療剤
JP2701932B2 (ja) * 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
JPH041737A (ja) * 1990-04-19 1992-01-07 Ricoh Co Ltd カメラの絞り装置
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
US5227401A (en) * 1991-10-29 1993-07-13 G. D. Searle & Co. Ethynyl alanine amino diol compounds for treatment of hypertension

Also Published As

Publication number Publication date
EP0578978B1 (de) 1997-01-15
US5399743A (en) 1995-03-21
JPH05345754A (ja) 1993-12-27
EP0578978A1 (de) 1994-01-19
DE69307414T2 (de) 1997-06-26
DE69307414D1 (de) 1997-02-27

Similar Documents

Publication Publication Date Title
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DK0513104T3 (da) Anvendelse af et alfa-tocopherolphosphat eller et af dets derivater til fremstilling af kosmetiske, dermatologiske eller farmaceutiske præparater, og således opnåede præparater
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
EP0930310A4 (de) Isocumarinderivate und deren verwendung in medikamenten
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
IL109615A (en) Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ES2143526T3 (es) Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos.
NZ270167A (en) Use of benzothiophene derivatives in the preparation of medicaments for treating dysfunctional uterine bleeding
AU626743B2 (en) Therapeutic application of fluoroquinolone derivatives for pneumocystosis
DE69001722T2 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
DE69118064D1 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
ATE184282T1 (de) Cyclopropan-derivate und diese enthaltende antivirale mittel
NO985202L (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
NO894325D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
ES2134441T3 (es) Benzonitrilos terapeuticos.
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties